Aosi Hui (奥司惠)奥司惠

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

阿法骨化醇是一种在国家药监局注册认定的药品。该药品含有开环胆甾、阿法骨化醇-38eb6e7a等成分。

该药品关联的活性成分包括:开环胆甾Kaihuan Danzai、阿法骨化醇Afa Guhua Chun。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:广州白云山星群(药业)股份有限公司Chinese legal name: 广州白云山星群(药业股份有限公司)。

您可以探索含有相同成分的其他药品:开环胆甾-dde62f71成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 奥司惠) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 开环胆甾Kaihuan Danzai, 阿法骨化醇Afa Guhua Chun.

Manufacturers recorded for this product: 广州白云山星群(药业)股份有限公司Chinese legal name: 广州白云山星群(药业股份有限公司).

Explore other medicines containing the same ingredient: 开环胆甾 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 奥司惠Recorded Chinese name: 奥司惠
  • 剂型Dosage form: 丸剂Pills
  • 规格Specification: 0.5μg0.5 μg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 广州白云山星群(药业)股份有限公司Chinese legal name: 广州白云山星群(药业股份有限公司)

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20051861

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20051861

Manufacturer

Chinese legal name: 广州白云山星群(药业)股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20051861

生产企业

广州白云山星群(药业)股份有限公司(国产)

适应症

1.骨质疏松症。|2.维生素D缺乏性佝偻病和软骨病,跖骨头骨软骨病。|3.肾性骨病。|4.甲状旁腺功能减退症。

用法用量

口服:|1.成人,慢性肾功能不全和骨质疏松症:每次0.5mg(2粒),每日1次,或遵医嘱。|2.儿童,应遵医嘱。

不良反应

1.小剂量单独使用(<1.0μg/d)一般无不良反应,长期大剂量用药或与钙剂合用可能会引起高钙血症和高钙尿症。|2.偶见食欲不振、恶心、呕吐及皮肤瘙痒感等。

禁忌

对维生素D及其类似物过敏、具有高钙血症、有维生素D中毒征象者禁用。

注意事项

1.青年患者只限用于青年特发性骨质疏松症及糖皮质激素过多引起的骨质疏松症。|2.用药过程中应注意监测血钙、血尿素氮、肌酐,以及尿钙、尿肌酐。|3.出现高钙血症时须停药,并予有关处理,待血钙恢复正常,按末次剂量减半给药。|4.超大剂量服药可能出现胃肠道系统、肝脏方面、精神神经系统、循环系统等方面的不良反应,如:胃痛、便秘、GOT及GPT升高、头痛、血压轻度升高等。

贮藏

密封,在避光处干燥处保存。

规格

0.5μg

证据Evidence

  • 批准文号: 国药准字H20051861
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.